NCT06273462View on ClinicalTrials.gov

Palmitoylethanolamide for Chronic Inflammatory Pain Conditions

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

October 30, 2025

Conditions
Chronic Pain
Interventions
DRUG

Palmitoylethanolamide 600mg twice a day

600mg palmitoylethanolamide twice a day

OTHER

placebo

visually identical placebo capsule

Trial Locations (1)

92118

RECRUITING

Naval Medical Center San Diego, San Diego

All Listed Sponsors
lead

Navy Medical Center San Diego

FED